Aspen API. More than just an API™
Reset all filters
01 1Aspen Oss B.V.
02 4Symbiotec Pharmalab Private Limited
03 1Dr. Reddy's Laboratories Limited
04 5Asclemed USA, Inc.
05 1Bayer AG
06 1COHESION BIOTEC PRIVATE LIMITED
07 1Curia Spain S.A.U.
08 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
09 1Fagron Services B.V.
10 1Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
11 1Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd
12 1Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
13 1Kalchem International inc
14 4LETCO MEDICAL, LLC
15 1MEDISCA Inc.
16 2Medisca Inc.
17 1PROFESSIONAL COMPOUNDING CENTER OF AMERICA
18 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
19 2Pharma Source Direct, Inc.
20 2Pharmacia and Upjohn Company LLC
21 1Productos Quimicos Naturales S.A. de C.V.
22 3Professional Compounding Centers of America
23 2Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
24 1SCH Global Services Private Limited
25 1SHAKTI LIFESCIENCE PRIVATE LIMITED
26 3Spectrum Laboratory Products, Inc.
27 1Steroid S.p.A.
28 3zhejiang xianju pharmaceutical co., Ltd.
Reset all filters
01 13TESTOSTERONE
02 1TESTOSTERONE BASE
03 1TESTOSTERONE DODECANOATE
04 1TESTOSTERONE EP-USP
05 1TESTOSTERONE MICRONIZED (YAM)
06 1TESTOSTERONE MICRONIZED SOY
07 2TESTOSTERONE NON MICRONIZED
08 1Testerone Micronized
09 18Testosterone
10 1Testosterone (Micronized)
11 2Testosterone Decanoate
12 1Testosterone Isocaproate
13 1Testosterone Non Micronized Soy
14 1Testosterone Phenylpropionate
15 1Testosterone tridecanoate
16 1Tetsoteron Micronized
17 1testosterone
Reset all filters
01 7China
02 1Germany
03 6India
04 2Italy
05 1Mexico
06 2Netherlands
07 20U.S.A
08 5United Kingdom
09 4Blank
NDC Package Code : 60870-0251
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22552-0009
Start Marketing Date : 2010-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-837
Start Marketing Date : 2010-01-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22552-0011
Start Marketing Date : 2010-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22552-0012
Start Marketing Date : 2010-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22552-0016
Start Marketing Date : 2010-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12866-1175
Start Marketing Date : 2017-05-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-0074
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-5020
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12875-8248
Start Marketing Date : 2010-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
37
PharmaCompass offers a list of Testosterone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Testosterone manufacturer or Testosterone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Testosterone manufacturer or Testosterone supplier.
PharmaCompass also assists you with knowing the Testosterone API Price utilized in the formulation of products. Testosterone API Price is not always fixed or binding as the Testosterone Price is obtained through a variety of data sources. The Testosterone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 17-beta-Hydroxyandrost-4-en-3-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17-beta-Hydroxyandrost-4-en-3-one, including repackagers and relabelers. The FDA regulates 17-beta-Hydroxyandrost-4-en-3-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17-beta-Hydroxyandrost-4-en-3-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17-beta-Hydroxyandrost-4-en-3-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17-beta-Hydroxyandrost-4-en-3-one supplier is an individual or a company that provides 17-beta-Hydroxyandrost-4-en-3-one active pharmaceutical ingredient (API) or 17-beta-Hydroxyandrost-4-en-3-one finished formulations upon request. The 17-beta-Hydroxyandrost-4-en-3-one suppliers may include 17-beta-Hydroxyandrost-4-en-3-one API manufacturers, exporters, distributors and traders.
click here to find a list of 17-beta-Hydroxyandrost-4-en-3-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17-beta-Hydroxyandrost-4-en-3-one as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17-beta-Hydroxyandrost-4-en-3-one API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17-beta-Hydroxyandrost-4-en-3-one as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17-beta-Hydroxyandrost-4-en-3-one and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17-beta-Hydroxyandrost-4-en-3-one NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17-beta-Hydroxyandrost-4-en-3-one suppliers with NDC on PharmaCompass.
We have 21 companies offering 17-beta-Hydroxyandrost-4-en-3-one
Get in contact with the supplier of your choice: